Can non‑typhoidal Salmonellae cause a bowel fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Non-Typhoidal Salmonellae Cause Bowel Fistula?

Yes, non-typhoidal Salmonella can cause bowel fistula, though this is an exceptionally rare complication that typically occurs in the setting of severe invasive disease with abscess formation or tissue necrosis.

Mechanism and Clinical Context

Non-typhoidal Salmonella (NTS) primarily causes self-limited gastroenteritis, but can lead to invasive extraintestinal complications in specific circumstances. Fistula formation occurs through two main pathways:

  • Direct tissue invasion with abscess formation: NTS can create abscesses in adjacent organs (spleen, ovary, gallbladder) that subsequently erode into bowel, creating fistulous tracts 1, 2
  • Ischemic necrosis and perforation: Large abscesses can compress bowel segments, leading to ischemic necrosis and subsequent fistula formation 2

Evidence for Bowel Fistula Formation

The documented cases demonstrate that NTS-related fistulas occur in specific clinical scenarios:

  • Entero-ovarian fistula: A case report documented direct spread of Salmonella through a fistula connecting an ovarian endometrioma to intestinal segments 1
  • Colo-splenic fistula: A chronic Salmonella typhi carrier developed a calcified splenic abscess that created a colonic fistula, likely from compression-induced ischemic necrosis of the left colon 2
  • Cholecystoenteric complications: Salmonella cholecystitis can lead to fistula formation between the gallbladder and adjacent bowel 3

Risk Factors and High-Risk Populations

Fistula formation is more likely in:

  • Immunocompromised hosts with prolonged or invasive disease
  • Patients with pre-existing structural abnormalities (cysts, endometriomas, gallstones)
  • Chronic carriers where persistent infection allows time for abscess maturation and erosion 2
  • Elderly patients with comorbidities who develop invasive NTS 4

Critical Pitfalls to Avoid

  • Don't assume NTS is always self-limited: While the 2017 IDSA guidelines note that symptoms can persist 10-14 days or longer 5, they do not specifically address rare complications like fistula formation
  • Consider invasive disease if symptoms worsen beyond 2 weeks: Persistent fever, systemic symptoms, or localized pain should prompt imaging to evaluate for abscess formation
  • Obtain cultures from suspected abscess sites: Blood and stool cultures may miss localized infections; tissue or abscess cultures are essential for diagnosis 1, 6
  • Watch for catastrophic complications: NTS can cause colonic perforation even in immunocompetent hosts 7, and fistulas represent a similar level of tissue destruction

Clinical Recognition

Look for these specific warning signs that suggest fistula formation rather than simple gastroenteritis:

  • Persistent fever beyond 2 weeks despite appropriate therapy
  • Localized abdominal pain with palpable mass
  • Signs of abscess (fluctuance, localized tenderness)
  • Cutaneous drainage or fistulous openings 6
  • Progressive systemic toxicity requiring ICU care (occurs in ~47% of invasive NTS cases) 4

The key clinical principle: While NTS-related bowel fistulas are rare, they represent severe invasive disease requiring surgical intervention combined with prolonged antimicrobial therapy. Early CT imaging is essential when clinical deterioration occurs beyond the expected gastroenteritis course 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.